The WTA method performed on a diverse set of clinical samples.

NOTE. WTA, Whole Transciptome Amplification; HSV1, Herpes Simplex virus 1; HSV2, Herpes Simplex virus 2; HPV, Human Papillomavirus; BKV, BK Polyomavirus; JCV, JC Polyomavirus; CSF, cerebrospinal fluid; Rota A, Rotavirus A; HCV, Hepatitis C virus; EV, Enterovirus; RSV, Respiratory Syncytial virus; TA, tracheal aspirate; n.a., not analysed.aViruses are grouped based on nucleic acid content, according to the Baltimore Classification.bDifference in Ct-value in virus-specific real-time PCR before and after Phi29-amplification.cFold increase of virus after Phi29-amplification, calculated from ΔCt combined with dilution factors for each sample.dOnly HPV6- and HPV16-specific real-time PCR's were performed.eSapovirus from a double-positive Astrovirus/Sapovirus faeces sample.fSapovirus from a single-positive Sapovirus faeces sample.